
About SISHU
Standardizing Infant Screening and Health for the Underserved

SISHU is a pioneering quality improvement initiative for advancing newborn screening in underserved areas developed through a joint collaboration between the Swami Vivekananda Youth Movement (SVYM) in India and UCLA Global Health. Dr. Kumar Suryanarayana, the visionary pediatrician behind this initiative, has for over a decade tried to bring equitable care for newborns at Vivekananda Memorial Hospital-- a rural hospital serving a population of approximately 300,000 rural-indigenous tribals in Saragur, Karnataka, India. Initial steps included a transcutaneous bilirubin screening programme in 2012 in collaboration with University of California, San Francisco, followed by the pioneering effort of introducing newborn genetic screening in rural areas, beginning with cord umbilical blood hemoglobin electrophoresis and TSH testing to address the high prevalence of sickle cell disease and congenital hypothyroidism among tribal-rural populations. Subsequently, he and Dr. Deepashree Ramachandra, an audiologist established a newborn hearing screening centre in collaboration with All India Institute for Speech and Hearing (AIISH), Mysuru, offering hearing screening to close to 3500 rural-tribal newborns born in that area annually. His tireless dedication has focused on bridging the gap toward equitable newborn care for vulnerable communities, guided by the vision that “every newborn thrives, and birth is not a barrier but a powerful beginning.”


Early Screening Matters

Building on this foundation, in partnership with Dr. Supriya Bavisetty, Associate Professor at UCLA and Director of Newborn Services at Olive View-UCLA Medical Center, and Dr. Kalpashri Kesavan, Associate Professor of Pediatrics in the Division of Neonatology at UCLA, Standardizing Infant Screening and Healthcare for the Underserved: SISHU initiative was launched in 2025. The mission of SISHU is to advance equitable newborn screening and quality of care in underserved regions of India by establishing a standardized, evidence-based model for neonatal/early infancy screening, diagnosis, referral follow up and management. The initiative encompasses comprehensive universal screening for critical congenital heart disease (CCHD), congenital hypothyroidism, hemoglobinopathies, hearing impairment, and hyperbilirubinemia, and hip dislocation, while also supporting timely diagnosis and management of hypoglycemia, sepsis, and early detection of cerebral palsy (CP) in high-risk infants. By streamlining workflows and enabling rural healthcare teams, SISHU reduces unnecessary patient transfers and improves outcomes directly at the point of care.
